![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
"A rare variant, which destroys a FoxA1 site at 8q24, is associated with prostate cancer risk." Cell Cycle, 12(2), pp. 379–380
Acknowledgments
This work was supported by the National Institutes of Health (R01 CA136924 and U19 CA148537 to G.A.C.) and from a subcontract (to G.A.C. from Harvard) of a David Mazzone award. The scientific development and funding of this project were in part supported by the Genetic Associations and Mechanisms in Oncology (GAME-ON), a NCI Cancer Post-GWAS Initiative.
Author Contributions
All three authors were involved in all aspects of the design, analyses and writing of the manuscript.